Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 19, 2017

Impax Announces Sale of Taiwan Manufacturing Facility

Dec 19, 2017

Amneal Brings Generic for Renvela® to Market

Dec 18, 2017

Robert Stewart to Join Amneal Pharmaceuticals as President

Dec 11, 2017

Only Generic for Kenalog-40 Injection Approved: Available through Amneal Biosciences

Dec 08, 2017

Impax Receives Tentative FDA Approval of Generic Coreg CR® (Carvedilol Phosphate) Extended-Release Capsules

Nov 28, 2017

Amneal Biosciences Introduces Generic Clolar®

Nov 09, 2017

Impax Reports Third Quarter 2017 Results

Nov 08, 2017

Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly

Nov 06, 2017

Impax Announces Successful Completion of Consent Solicitation with Respect to its 2.00% Convertible Senior Notes due 2022

Oct 30, 2017

Impax Announces Consent Solicitation

Oct 24, 2017

Amneal wins Leader of the Year & Company of the Year, Americas Awards

Oct 23, 2017

Impax Announces FDA Approval and Launch of Generic Renvela® (Sevelamer Carbonate) Tablets, 800 mg

Oct 17, 2017

Amneal And Impax To Combine

Oct 03, 2017

Impax to Report Third Quarter 2017 Results on November 9, 2017

Sep 28, 2017

Amneal Generic for Minastrin® 24 Fe Now Available

Sep 19, 2017

Impax to Present at the Cantor Fitzgerald Global Healthcare Conference

Sep 05, 2017

Impax to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

Aug 14, 2017

Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product

Aug 09, 2017

Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million

Aug 07, 2017

Amneal Oseltamivir Capsules, Generic for Tamiflu®, Now Available

Aug 07, 2017

Impax Announces Settlement of Contract Litigation on Opana® ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets

Jul 17, 2017

Impax Announces FDA Approval of its AB Rated Generic Concerta® (Methylphenidate Hydrochloride) Extended-Release Tablets CII

Jul 05, 2017

Impax Announces FDA Approval and Launch of Additional Strengths of Generic Focalin XR® (Dexmethylphenidate Hydrochloride) Extended-Release Capsules CII

Jun 29, 2017

Impax to Report Second Quarter 2017 Results on August 9, 2017

Jun 15, 2017

Amneal Introduces Ezetimibe Tablets, New Generic for Zetia®

Jun 08, 2017

Impax to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

May 17, 2017

Impax to Present at the UBS Global Healthcare Conference

May 11, 2017

Impax to Present at the Bank of America Merrill Lynch Healthcare Conference

May 10, 2017

Impax Reports First Quarter 2017 Financial Results

Apr 27, 2017

First FDA-Approved 100 mg Thiotepa Now Available through Amneal Biosciences as TEPADINA® (thiotepa) for Injection

Apr 26, 2017

Impax Announces FDA Approval and Launch of a Generic Version of Vytorin® (Ezetimibe/Simvastatin Tablets)

Apr 21, 2017

Impax to Present Data on Rytary® (Carbidopa and Levodopa) Extended-Release Capsules, Zomig® (Zolmitriptan) Nasal Spray and Investigational Drug IPX203 at the 2017 American Academy of Neurology® Annual Meeting

Apr 11, 2017

Amneal Introduces Its First Nasal Spray: Generic Nasonex®

Apr 06, 2017

Impax to Report First Quarter 2017 Results on May 10, 2017

Mar 30, 2017

Impax Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray

Mar 28, 2017

Amneal Biosciences Announces Launch of Levoleucovorin for Injection

Mar 27, 2017

Impax Board of Directors Appoints Paul M. Bisaro President and CEO

Mar 01, 2017

Impax Reports Fourth Quarter and Full Year 2016 Financial Results

Feb 27, 2017

Impax to Present at Upcoming Investor Conferences

Jan 31, 2017

Amneal Biosciences Introduces Third Institutional Product

Jan 30, 2017

Amneal Introduces Alosetron Hydrochloride Tablets, New Generic for Lotronex®

Jan 25, 2017

Impax to Report Fourth Quarter and Full Year 2016 Results on March 1, 2017

Jan 06, 2017

Impax Confirms Patent Challenge Relating to Generic Aubagio® (teriflunomide) Tablets, 14 mg

Jan 04, 2017

Impax to Present at 35th Annual J.P. Morgan Healthcare Conference

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14